A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Sponsor
Incyte

Protocol Number
Incyte INCB 50465-201

To Learn More Call
201-510-0910